Relationship between serum secreted frizzled-related protein 4 levels and the first-phase of glucose-stimulated insulin secretion in individuals with different glucose tolerance

Endocrine Journal

Volumn 62, Issue 8, 2015, Pages 733-740

  Liu, Fang ^a   Qu, Hua ^a   Li, Yingjie ^a   Tang, Qian ^a   Yang, Zesong ^a   Wang, Hang ^a   Deng, Huacong ^a  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Diabetes; First phase of insulin secretion; IL 1 ; Intravenous glucose tolerance test; Secreted frizzled related protein 4

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 1BETA; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SECRETED FRIZZLED RELATED PROTEIN 4; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL; INSULIN; ONCOPROTEIN; SFRP4 PROTEIN, RAT;

ACUTE INSULIN RESPONSE; ADULT; AREA UNDER THE CURVE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHRONIC INFLAMMATION; CONTROLLED STUDY; CORRELATIONAL STUDY; CROSS-SECTIONAL STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE DISPOSITION INDEX; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HOMEOSTASIS MODEL ASSESSMENT BETA CELL FUNCTION; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN RESPONSE; INTRAVENOUS GLUCOSE TOLERANCE TEST; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL; BLOOD; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; METABOLISM; PHYSIOLOGY;

ADULT; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS;

EID: 84940492314     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ15-0212     Document Type: Article

References (32)

1. Festa A, Williams K, Hanley AJ, Haffner SM (2008) Beta-cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: comparison of surrogate markers with first-phase insulin secretion from an intravenous glucose tolerance test. Diabetes 57: 1638-1644.
2. Osborn O, Olefsky JM (2012) The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med 18: 363-374.
3. Kaneto H, Nakatani Y, Kawamori D, Miyatsuka T, Matsuoka TA (2004) Involvement of oxidative stress and the JNK pathway in glucose toxicity. Rev Diabet Stud 1: 165-174.
4. Maedler K, Sergeev P, Ehses JA, Mathe Z, Bosco D, et al. (2004) Leptin modulates beta cell expression of IL-1 receptor antagonist and release of IL-1beta in human islets. Proc Natl Acad Sci U S A 101: 8138-8143.
5. Akash MS, Rehman K, Chen S (2013) Role of inflammatory mechanisms in pathogenesis of type 2 diabetes mellitus. J Cell Biochem 114: 525-531.
6. Al-Shukaili A, Al-Ghafri S, Al-Marhoobi S, Al-Abri S, Al-Lawati J, et al. (2013) Analysis of inflammatory mediators in type 2 diabetes patients. Int J Endocrinol 2013: 976810.
7. Igoillo-Esteve M, Marselli L, Cunha DA, Ladriere L, Ortis F, et al. (2010) Palmitate induces a pro-inflammatory response in human pancreatic islets that mimics CCL2 expression by beta cells in type 2 diabetes. Diabetologia 53: 1395-1405.
8. Boni-Schnetzler M, Thorne J, Parnaud G, Marselli L, Ehses JA, et al. (2008) Increased interleukin (IL)-1beta messenger ribonucleic acid expression in beta -cells of individuals with type 2 diabetes and regulation of IL-1beta in human islets by glucose and autostimulation. J Clin Endocrinol Metab 93: 4065-4074.
9. Dula SB, Jecmenica M, Wu R, Jahanshahi P, Verrilli GM, et al. (2010) Evidence that low-grade systemic inflammation can induce islet dysfunction as measured by impaired calcium handling. Cell Calcium 48: 133-142.
10. Maedler K, Sergeev P, Ris F, Oberholzer J, Joller-Jemelka HI, et al. (2002) Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets. J Clin Invest 110: 851-860.
11. Dunmore SJ, Brown JE (2013) The role of adipokines in beta-cell failure of type 2 diabetes. J Endocrinol 216: T37-45.
12. Imai Y, Dobrian AD, Morris MA, Nadler JL (2013) Islet inflammation: a unifying target for diabetes treatment? Trends Endocrinol Metab 24: 351-360.
13. Mahdi T, Hanzelmann S, Salehi A, Muhammed SJ, Reinbothe TM, et al. (2012) Secreted frizzled-related protein 4 reduces insulin secretion and is overexpressed in type 2 diabetes. Cell Metab 16: 625-633.
14. Ehrlund A, Mejhert N, Lorente-Cebrian S, Astrom G, Dahlman I, et al. (2013) Characterization of the Wnt inhibitors secreted frizzled-related proteins (SFRPs) in human adipose tissue. J Clin Endocrinol Metab 98: E503-508.
15. Ljunggren S, Hahn RG, Nystrom T (2014) Insulin sensitivity and beta-cell function after carbohydrate oral loading in hip replacement surgery: a double-blind, randomised controlled clinical trial. Clin Nutr 33: 392-398.
16. Alberti KG, Zimmet PZ (1998) Definition, d iagnosisand classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15: 539-553.
17. Xu P, Wu Y, Zhu Y, Dagne G, Johnson G, et al. (2010) Prognostic performance of metabolic indexes in predicting onset of type 1 diabetes. Diabetes Care 33: 2508-2513.
18. Pacini G, Bergman RN (1986) MINMOD: a compute rprogram to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comput Methods Programs Biomed 23: 113-122.
19. Rosenbaum M, Nonas C, Horlick M, Fennoy I, Vargas I, et al. (2004) beta-Cell function and insulin sensitivity in early adolescence: association with body fatness and family history of type 2 diabetes mellitus. J Clin Endocrinol Metab 89: 5469-5476.
20. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, et al. (1993) Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42: 1663-1672.
21. Rattner A, Hsieh JC, Smallwood PM, Gilbert DJ, Copeland NG (1997) A family of secreted proteins contains homology to the cysteine-rich ligand-binding domain of frizzled receptors. Proc Natl Acad Sci U S A 94: 2859-2863.
22. Bafico A, Gazit A, Pramila T, Finch PW, Yaniv A, et al. (1999) Interaction of frizzled related protein (FRP) with Wnt ligands and the frizzled receptor suggests alternative mechanisms for FRP inhibition of Wnt signaling. J Biol Chem 274: 16180-16187.
23. Taneera J, Lang S, Sharma A, Fadista J, Zhou Y, et al.(2012) A systems genetics approach identifies genes and pathways for type 2 diabetes in human islets. Cell Metab 16: 122-134.
24. Berndt T, Kumar R (2007) Phosphatonins and the regulation of phosphate homeostasis. Annu Rev Physiol 69: 341-359.
25. Carmon KS, Loose DS (2008) Secreted frizzled-related protein 4 regulates two Wnt7a signaling pathways and inhibits proliferation in endometrial cancer cells. Mol Cancer Res 6: 1017-1028.
26. Lacher MD, Siegenthaler A, Jaeger R, Yan X (2003) Role of DDC-4/sFRP-4, a secreted frizzled-related protein, at the onset of apoptosis in mammary involution. Cell Death Differ 10: 528-538.
27. Maganga R, Giles N, Adcroft K, Unni A, Keeney D, et al. (2008) Secreted Frizzled related protein-4 (sFRP4) promotes epidermal differentiation and apoptosis. Biochem Biophys Res Commun 377: 606-611.
28. Wisniewska MB, Misztal K, Michowski W, Szczot M, Purta E, et al. (2010) LEF1/beta-catenin complex regulates transcription of the Cav3.1 calcium channel gene (Cacna1g) in thalamic neurons of the adult brain. J Neurosci 30: 4957-4969.
29. Masters SL, Dunne A, Subramanian SL, Hull RL, Tannahill GM, et al. (2010) Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1beta in type 2 diabetes. Nat Immunol 11: 897-904.
30. Nicol LE, Grant WF, Comstock SM, Nguyen ML, Smith MS, et al. (2013) Pancreatic inflammation and increased islet macrophages in insulin-resistant juvenile primates. J Endocrinol 217: 207-213.
31. Donath MY, Storling J, Berchtold LA, Billestrup N, Mandrup-Poulsen T (2008) Cytokines and beta-cell biology: from concept to clinical translation. Endocr Rev 29: 334-350.
32. Wilson C (2013) Diabetes: SFRP4-a biomarker for islet dysfunction? Nat Rev Endocrinol 9: 65.